320 related articles for article (PubMed ID: 28223384)
1. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 5 of Human Pathogen Candida albicans Carries Multiple Genes for Negative Control of Caspofungin and Anidulafungin Susceptibility.
Suwunnakorn S; Wakabayashi H; Rustchenko E
Antimicrob Agents Chemother; 2016 Dec; 60(12):7457-7467. PubMed ID: 27736768
[TBL] [Abstract][Full Text] [Related]
3. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
Imtiaz T; Lee KK; Munro CA; MacCallum DM; Shankland GS; Johnson EM; MacGregor MS; Bal AM
J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals.
Yang F; Kravets A; Bethlendy G; Welle S; Rustchenko E
Antimicrob Agents Chemother; 2013 Oct; 57(10):5026-36. PubMed ID: 23896475
[TBL] [Abstract][Full Text] [Related]
5. A Candida albicans strain with high MIC for caspofungin and no FKS1 mutations exhibits a high chitin content and mutations in two chitinase genes.
Drakulovski P; Dunyach C; Bertout S; Reynes J; Mallié M
Med Mycol; 2011 Jul; 49(5):467-74. PubMed ID: 21108572
[TBL] [Abstract][Full Text] [Related]
6. Elevated chitin content reduces the susceptibility of Candida species to caspofungin.
Walker LA; Gow NA; Munro CA
Antimicrob Agents Chemother; 2013 Jan; 57(1):146-54. PubMed ID: 23089748
[TBL] [Abstract][Full Text] [Related]
7. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
Cheung YY; Hui M
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
[TBL] [Abstract][Full Text] [Related]
8. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
[TBL] [Abstract][Full Text] [Related]
9. Multiple Genes of Candida albicans Influencing Echinocandin Susceptibility in Caspofungin-Adapted Mutants.
Sah SK; Bhattacharya S; Yadav A; Husain F; Ndiaye ABKT; Kruppa MD; Hayes JJ; Rustchenko E
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0097722. PubMed ID: 36354349
[TBL] [Abstract][Full Text] [Related]
10. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
Healey KR; Nagasaki Y; Zimmerman M; Kordalewska M; Park S; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
[No Abstract] [Full Text] [Related]
11. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
Rueda C; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
[TBL] [Abstract][Full Text] [Related]
12. Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
Wiederhold NP; Grabinski JL; Garcia-Effron G; Perlin DS; Lee SA
Antimicrob Agents Chemother; 2008 Nov; 52(11):4145-8. PubMed ID: 18794385
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin-induced β(1,3)-glucan exposure in
Wagner AS; Lumsdaine SW; Mangrum MM; Reynolds TB
mBio; 2023 Aug; 14(4):e0007423. PubMed ID: 37377417
[TBL] [Abstract][Full Text] [Related]
14. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1.
Balashov SV; Park S; Perlin DS
Antimicrob Agents Chemother; 2006 Jun; 50(6):2058-63. PubMed ID: 16723566
[TBL] [Abstract][Full Text] [Related]
15. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
[TBL] [Abstract][Full Text] [Related]
16. New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species.
Johnson ME; Katiyar SK; Edlind TD
Antimicrob Agents Chemother; 2011 Aug; 55(8):3774-81. PubMed ID: 21576441
[TBL] [Abstract][Full Text] [Related]
17. Efg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1.
Gregori C; Glaser W; Frohner IE; Reinoso-Martín C; Rupp S; Schüller C; Kuchler K
Eukaryot Cell; 2011 Dec; 10(12):1694-704. PubMed ID: 22037180
[TBL] [Abstract][Full Text] [Related]
18. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
Toutounji M; Tokajian S; Khalaf RA
Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
[TBL] [Abstract][Full Text] [Related]
19. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
Lee KK; Maccallum DM; Jacobsen MD; Walker LA; Odds FC; Gow NA; Munro CA
Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale effects of caspofungin against two yeast species, Saccharomyces cerevisiae and Candida albicans.
Formosa C; Schiavone M; Martin-Yken H; François JM; Duval RE; Dague E
Antimicrob Agents Chemother; 2013 Aug; 57(8):3498-506. PubMed ID: 23669379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
